jonboixxx
Active Member
- Joined
- Jan 2, 2014
- Posts
- 607
- Qantas
- Platinum
- Virgin
- Platinum
- Star Alliance
- Gold
You have a lot of snippets collated there. 20-20 hindsight is a wonderful thing.
Wasn't Marburg the facility they bought from Novartis in Sep 2020, and is it actually in distribution mode yet.
BionTech was running with $750M funding from Pfizer for some 12 months and to their credit managed to do this in one of the industrial giants in the world, Germany.
I am not against developing new vaccine technologies in readiness for the next inevitable, globalised pandemic but chasing after mRNA producing capacity may be already outmoded, with exponential advancements in vaccine technology.
50,000 step process exported to Oz, in an old GSK facility, with no capacity for their specialised lipid technologies; simples!A much shorter time frame is not only possible but has been achieved (from start to finish) by Germany in just over 3 to 4 months in Marburg for example.
Wasn't Marburg the facility they bought from Novartis in Sep 2020, and is it actually in distribution mode yet.
BionTech was running with $750M funding from Pfizer for some 12 months and to their credit managed to do this in one of the industrial giants in the world, Germany.
I am not against developing new vaccine technologies in readiness for the next inevitable, globalised pandemic but chasing after mRNA producing capacity may be already outmoded, with exponential advancements in vaccine technology.